Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Gains from Investment Securities (2016 - 2025)

InspireMD (NSPR) has 15 years of Gains from Investment Securities data on record, last reported at $55000.0 in Q3 2025.

  • For Q3 2025, Gains from Investment Securities rose 150.0% year-over-year to $55000.0; the TTM value through Sep 2025 reached $156000.0, up 81.4%, while the annual FY2024 figure was $51000.0, 750.0% up from the prior year.
  • Gains from Investment Securities reached $55000.0 in Q3 2025 per NSPR's latest filing, up from $3000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $10.0 million in Q2 2022 and bottomed at -$10.1 million in Q3 2022.
  • Average Gains from Investment Securities over 5 years is $2222.2, with a median of $5000.0 recorded in 2022.
  • Peak YoY movement for Gains from Investment Securities: surged 62643.75% in 2022, then plummeted 214.29% in 2023.
  • A 5-year view of Gains from Investment Securities shows it stood at $2000.0 in 2021, then surged by 250.0% to $7000.0 in 2022, then soared by 1014.29% to $78000.0 in 2023, then plummeted by 44.87% to $43000.0 in 2024, then rose by 27.91% to $55000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were $55000.0 in Q3 2025, $3000.0 in Q2 2025, and $55000.0 in Q1 2025.